Skip to main content
OpenTrials

Clinical trial condition

Inflammatory Bowel Diseases

Explore clinical trials studying Inflammatory Bowel Diseases. Study availability and eligibility vary by location and protocol.

1,522 public trials 287 recruiting studies
Refine in advanced search Browse all conditions

Inflammatory Bowel Diseases trial results

Active, Not Recruiting

A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease

NCT05242471

Conditions
Crohn Disease, Crohn's Disease, Digestive System Diseases, +4 more
Locations
  • University of Alabama Liver Center Birmingham, Alabama, United States
  • Del Sol Research Management, LLC Tucson, Arizona, United States
  • Moore Clinical Trials, LLC Little Rock, Arkansas, United States
  • Om Research LLC Apple Valley, California, United States
View all 456 locations
View Trial Details
Active, Not Recruiting

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis

NCT06260163

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +5 more
Locations
  • Children's Hospital Oakland Oakland, California, United States
  • Riley Hospital for Children Indianapolis, Indiana, United States
  • NYU Langone Health Lake Success, New York, United States
  • The Kids Research Institute Australia on behalf of the Centre for Child Health Research Nedlands, Australia
View all 61 locations
View Trial Details
Active, Not Recruiting

A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

NCT03466411

Conditions
Crohn Disease, Crohn's Disease, Digestive System Diseases, +4 more
Locations
  • Digestive Health Specialists of the Southeast Dothan, Alabama, United States
  • Internal Medicine Center Mobile, Alabama, United States
  • University of Arizona Tucson, Arizona, United States
  • Advanced Research Center Inc Anaheim, California, United States
View all 577 locations
View Trial Details
Active, Not Recruiting

A Long-term Extension Study of Ustekinumab in Pediatric Participants

NCT05092269

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +19 more
Locations
  • Children's Center For Digestive Healthcare, Llc Atlanta, Georgia, United States
  • Mount Sinai New York, United States
  • Levine Childrens at Atrium Health Charlotte, North Carolina, United States
  • Pediatric Specialists Of Virginia Fairfax, Virginia, United States
View all 48 locations
View Trial Details
Active, Not Recruiting

A Study of Filgotinib 200 mg in Korean Participants With Moderately to Severely Active Ulcerative Colitis Under Routine Clinical Practice

NCT06964113

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • Eisai Site #13 Busan, South Korea
  • Eisai Site #15 Busan, South Korea
  • Eisai Site #8 Busan, South Korea
  • Eisai Site #6 Daegu, South Korea
View all 19 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab))

NCT05731128

Conditions
Colitis, Colitis Ulcerative, Colitis, Ulcerative, +6 more
Locations
  • Om Research- Site Number : 8400029 Apple Valley, California, United States
  • TLC Clinical Research- Site Number : 8400020 Beverly Hills, California, United States
  • Om Research - Oxnard- Site Number : 8400028 Oxnard, California, United States
  • Palmtree Clinical Research- Site Number : 8400048 Palm Springs, California, United States
View all 77 locations
View Trial Details
Active, Not Recruiting

Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease

NCT05910528

Conditions
Crohn Disease, Crohns Disease, Digestive System Diseases, +4 more
Locations
  • Digestive Health Specialists Dothan, Alabama, United States
  • Medical Research Center of Connecticut, LLC Hamden, Connecticut, United States
  • I.H.S Health Northwell Health Kissimmee, Florida, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis

NCT04624230

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California, San Francisco Benioff Children's Hospital San Francisco, California, United States
  • University of California, San Francisco Pediatric Clinical Research Center (PCRC) San Francisco, California, United States
  • Connecticut Children's Ambulatory Surgical Center Farmington, Connecticut, United States
View all 69 locations
View Trial Details
Active, Not Recruiting

A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease

NCT04738942

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +8 more
Locations
  • Ieda Hospital Toyota, Aichi-ken, Japan
  • Hirosaki University Hospital Hirosaki, Aomori, Japan
  • Tsujinaka Hospital Kashiwa, Chiba, Japan
  • Toho University Sakura Medical Center Sakura, Chiba, Japan
View all 20 locations
View Trial Details

Related conditions